BNP/PUT/ROCHE GS/205/0.1/20.09.24 Share Price

Warrant

DE000PC5CQY9

Market Closed - Boerse Frankfurt Warrants 15:21:17 01/07/2024 BST
0.068 EUR -4.23% Intraday chart for BNP/PUT/ROCHE GS/205/0.1/20.09.24
Current month-4.23%
1 month-69.09%
Date Price Change
01/07/24 0.068 -4.23%
28/06/24 0.071 -1.39%
27/06/24 0.072 -6.49%
26/06/24 0.077 +6.94%
25/06/24 0.072 +7.46%

Real-time Boerse Frankfurt Warrants

Last update July 01, 2024 at 03:21 pm

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5CQY
ISINDE000PC5CQY9
Date issued 20/02/2024
Strike 205 CHF
Maturity 20/09/2024 (81 Days)
Parity 10 : 1
Emission price 0.52
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.61
Lowest since issue 0.063
Delta-0.05x
Omega 17.94
Premium18.31x
Gearing358.06x
Moneyness 0.8197
Difference Strike -45.1 CHF
Difference Strike %-22.00%
Spread 0.01
Spread %12.99%
Theoretical value 0.0720
Implied Volatility 27.09 %
Total Loss Probability 93.55 %
Intrinsic value 0.000000
Present value 0.0720
Break even 204.30 €
Theta-0.01x
Vega0.01x
Rho-0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
250.1 CHF
Average target price
278.1 CHF
Spread / Average Target
+11.18%
Consensus